ArticleThe oncologist2025

Treatment, outcomes, and resource utilization among patients with metastatic breast and advanced epithelial ovarian cancer, by BRCA1/2 and HRD status.

Giovanna I Cruz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.